Latest Cholesterol Stories
All six trials met primary efficacy endpoint TARRYTOWN, N.Y. and PARIS, Nov. 19, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.
Two New Research Studies Provide Further Support for the Potential Role of CSL112 in the Reduction of Early Recurrent Cardiovascular Events following Myocardial Infarction KING OF
A new study at Sahlgrenska Academy confirms that moderate alcohol consumption can protect against coronary heart disease. But only for the 15% of the population that have a particular genotype.
RESEARCHERS FIND RARE, LOSS-OF-FUNCTION MUTATIONS THAT LOWER BLOOD CHOLESTEROL AND REDUCE RISK OF HEART ATTACK CAMBRIDGE, Mass., Nov.
Thirteen Presentations Include New Analyses of PCSK9 Inhibitor at Upcoming American Heart Association Scientific Sessions THOUSAND OAKS, Calif., Nov.
CSL112 Represents a Promising Investigational Therapy That May Fill a Void in Reducing Early Recurrent Cardiovascular Events in Patients Who Have Suffered a Heart Attack KING OF PRUSSIA, Pa.,
THOUSAND OAKS, Calif., Nov. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.
STOLBERG, Germany, November 7, 2014 /PRNewswire/ -- The individual risk of stroke, kidney failure and heart attack is the decisive factor over whether to start treatment
Diet Doc understands that learning how to lower bad cholesterol levels through diet can be challenging.
- A political dynamiter.
More Images (1 images) »